Skip to search formSkip to main contentSkip to account menu

40 ML obinutuzumab 25 MG/ML Injection [Gazyva]

Known as: Gazyva 1000 MG in 40 ML Injection, Gazyva 1000 MG per 40 ML Injection, OBINUTUZUMAB 1000 mg in 40 mL INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE [Gazyva] 
National Institutes of Health

Related topics

Related topics

9 relations
GazyvaHISTIDINE MONOHYDROCHLORIDE MONOHYDRATEHistidineInjection

Broader (1)

obinutuzumab Injection [Gazyva]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Safety and Efficacy of a Combination of Venetoclax (GDC-0199/ABT-199) and Obinutuzumab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia - Results from a Phase…
![Graphic][1] Introduction Treatment of patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) with… 
2014
2014
Obinutuzumab (Gazyva®) for previously untreated patients with chronic lymphocytic leukaemia (CLL)
Chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia, accounting for approximately 25 to 30 percent of all… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)